✦ LIBER ✦

293: Allogeneic Hematopoietic Cell Transplantation (HCT) in Chemotherapy Refractory Chronic Lymphocytic Leukemia (CLL)

✍ Scribed by O.S. Aljitawi; A. Krishnan; A. Nademanee; J. Palmer; J. Alvarnas; J.-L. Cai; M. Kirschbaum; N. Kogut; R. Nakamura; L. Popplewell; C. Sarkodee-Adoo; J. Schriber; J. Zain; P. Parker; S. Forman

Book ID: 116280120
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 62 KB
Volume: 14
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2007.12.303

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

95: Autologous hematopoietic cell transp

95: Autologous hematopoietic cell transplantation (auto-HCT) in chronic lymphocytic leukemia (CLL): Results of a systematic review

✍ M.A. Kharfan-Dabaja; A. Kumar; M. Behera; T. Field; E. Ayala; L. Perez; H. Ferna 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

368: Longer follow up of patients (pts)

368: Longer follow up of patients (pts) with advanced chronic lymphocytic leukemia (CLL) treated with nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT)

✍ M.L. Sorror; B. Storer; B.M. Sandmaier; M.B. Maris; J. Shizuru; D. Niederwieser; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Tandem Autologous and Nonmyeloablative A

Tandem Autologous and Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) from HLA-matched Related Or Unrelated Donors for Advanced Lymphoma Or Chronic Lymphocytic Leukemia (CLL)

✍ M.L. Sorror; B. Storer; B.M. Sandmaier; T. Chauncey; R.F. Storb; D.G. Maloney 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Treatment of patients (pts) with chemoth

Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)

✍ M.L. Sorror; M.B. Maris; B.M. Sandmaier; M. Jain-Stuart; B. Storer; U. Hegenbart 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Early Results of a Phase II Study Adding

Early Results of a Phase II Study Adding Peri-Transplant Rituximab to Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients (PTS) with High-Risk Fludarabine-Refractory Chronic Lymphocytic Leukemia (Cll)

✍ M.L. Sorror; B. Storer; B.M. Sandmaier; T. Chauncey; B. Bruno; N.N.S. Andersen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Outcomes After Allogeneic Hematopoietic

Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation For Patients With Advanced Chronic Lymphocytic Leukemia

✍ A. Rashed; S. Corringham; J.E. Castro; T.J. Kipps; E.D. Ball 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB